Purchases and Sales Made in Q4 2022 in Igm Biosciences, Inc. (IGMS)
This table provides information about the institutional ownership of Igm Biosciences, Inc. (IGMS) during Q4 2022. The information is specifically focused on institutions that hold shares of IGM Biosciences, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 23, 2023
Q4 2022
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-59- 2.16% |
$912 - $1.54K
|
2.67K
$17.4K
|
|
Jan 24, 2023
Q4 2022
|
Lindbrook Capital, LLC
|
SELL
|
- |
-70- 9.21% |
$1.08K - $1.82K
|
690
$4.49K
|
|
Jan 27, 2023
Q4 2022
|
Signaturefd, LLC
Atlanta, GA |
SELL
|
- |
-113- 12.7% |
$1.75K - $2.94K
|
777
$5.06K
|
|
Nov 30, 2023
Q4 2022
|
Pfs Partners, LLC
Mine Hill, NJ |
SELL
|
- |
-230Closed |
$3.55K - $5.98K
|
0
$0
|
|
Feb 14, 2023
Q4 2022
|
Virtus ETF Advisers LLC
New York, NY |
SELL
|
- |
-241- 3.29% |
$3.72K - $6.27K
|
7.08K
$46.1K
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-284- 69.44% |
$4.39K - $7.39K
|
125
$814
|
|
Feb 13, 2023
Q4 2022
|
Us Bancorp \De\
|
SELL
|
- |
-1.03K- 70.53% |
$16K - $26.9K
|
432
$2.81K
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.42K- 70.38% |
$22K - $37K
|
598
$3.89K
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.81K- 8.33% |
$27.9K - $47K
|
19.9K
$129K
|
|
Feb 14, 2023
Q4 2022
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-2.49K- 18.93% |
$38.4K - $64.7K
|
10.6K
$69.3K
|
|
Feb 13, 2023
Q4 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-4.43K- 45.42% |
$68.5K - $115K
|
5.33K
$34.7K
|
|
Feb 14, 2023
Q4 2022
|
Vident Investment Advisory, LLC
Alpharetta, GA |
SELL
|
- |
-4.73K- 10.69% |
$73K - $123K
|
39.5K
$257K
|
|
Feb 14, 2023
Q4 2022
|
Putnam Investments LLC
Boston, MA |
SELL
|
- |
-5.09K- 25.14% |
$78.6K - $132K
|
15.1K
$98.6K
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-8.26K- 8.26% |
$128K - $215K
|
91.7K
$597K
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-11.4K- 0.51% |
$175K - $296K
|
2.21M
$14.4M
|
|
Feb 02, 2023
Q4 2022
|
Simplex Trading, LLC
|
SELL
|
- |
-20.4K- 64.17% |
$315K - $530K
|
11.4K
$74.1K
|
|
Feb 14, 2023
Q4 2022
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-39.6K- 7.56% |
$612K - $1.03M
|
485K
$3.16M
|
|
Feb 14, 2023
Q4 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-50K- 25.02% |
$773K - $1.3M
|
150K
$977K
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-50.3K- 20.2% |
$778K - $1.31M
|
199K
$1.3M
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-50.3K- 20.2% |
$778K - $1.31M
|
199K
$1.3M
|
|
Feb 13, 2023
Q4 2022
|
Alkeon Capital Management LLC
New York, NY |
SELL
|
- |
-128K- 13.35% |
$1.98M - $3.34M
|
833K
$5.42M
|